Advertisement

Lymphomas and Total Body Irradiation

  • Murat Beyzadeoglu
  • Gokhan Ozyigit
  • Ugur Selek
  • Ugur Selek
Chapter

Abstract

This book, arranged in an MCQ format complemented by oral exam questions, is designed to meet the needs of a wide range of examinees. Essential aspects of radiation physics, radiobiology, and clinical radiation oncology are well covered. Tumors at different sites are addressed in a series of individual chapters, and further chapters are devoted to lymphomas and total body irradiation, pediatric tumors, and rare tumors and benign diseases. The answer keys provide clear explanations for both the correct answers and incorrect statements.

Keywords

Mantle Cell Lymphoma Total Body Irradiation Sezary Syndrome Extranodal Involvement Cutaneous Lymphoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Mann RB, Jaffe ES, Berard CW (1979) Malignant lymphomas a conceptual understanding of morphologic diversity. A review. Am J Pathol 94:105PubMedGoogle Scholar
  2. 2.
    Hummel M (2007) World Health Organization and beyond: new aspects in the pathology of an old disease. Hematol Oncol Clin North Am 21(5):769–786. ReviewPubMedCrossRefGoogle Scholar
  3. 3.
    Diehl V, Harris NL, Mauch PM (2005) Hodgkin’s lymphoma. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2021–2026Google Scholar
  4. 4.
    Mueller NE, Grufferman S, Chang ET (2007) The epidemiology of Hodgkin lymphoma. In: Hoppe RT, Mauch PM, Armitage JO, Diehl V, Weiss LM (eds) Hodgkin lymphoma, 2nd edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  5. 5.
    Diehl V, Harris NL, Mauch PM (2005) Hodgkin’s lymphoma. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia, p 2030Google Scholar
  6. 6.
    Edge SB et al (2010) Lymphoid neoplasms. In: Edge SB, American Joint Committee on Cancer et al (eds) AJCC cancer staging manual, 7th edn. Springer, New York, p 599Google Scholar
  7. 7.
    Lee CKK (2006) Radiotherapy for Hodgkin’s disease. In: Levitt SH, Purdy JA, Perez CA, Vijayakumar S (eds) Technical basis of radiation therapy, 4th rev. edn. Lippincott Raven Publishers, Philadelphia, p 806Google Scholar
  8. 8.
    Hansen EK, Roach M III (2006) Handbook of evidence-based radiation oncology. Springer, New York, pp 383–384Google Scholar
  9. 9.
    CKK Lee (2006) Radiotherapy for Hodgkin’s Disease. In: Levitt SH, Purdy JA, Perez CA, Vijayakumar S (eds) Technical basis of radiation therapy, 4th rev. edn. Lippincott Raven Publishers, Philadelphia, pp 815–818Google Scholar
  10. 10.
    Müller RP, Bischof M (2006) Tumoren des lymphatischen systems. In: Wannenmacher M, Debus J, Wenz F (eds) Strahlentherapie. Springer, Berlin, pp 658–693Google Scholar
  11. 11.
    Munker R, Marion J, Ye G, Dreyling MH (2007) The Non-Hodgkin’s lymphomas. In: Munker R, Hiller E, Glass J, Paquette R (eds) Modern hematology biology and clinical management. Humana-Press, Totowa, pp 237–250Google Scholar
  12. 12.
    Hansen EK, Roach M III (2006) Handbook of evidence-based radiation oncology. Springer, New York, pp 396–397Google Scholar
  13. 13.
    Burg G, LeBoit PE, Kempf W, Müller B, Leung KS, Springhouse, St. Anthony, Ko PY (2006) Cutaneous lymphomas: unusual cases. Steinkopff, Darmstadt, pp 2–12Google Scholar
  14. 14.
    American Joint Committee on Cancer (2002) Lymphoid neoplasms. In: AJCC cancer staging manual, 6th edn. Springer, New York, pp 393–406Google Scholar
  15. 15.
    Hansen EK, Roach M III (2006) Handbook of evidence-based radiation oncology. Springer, New York, pp 404–406Google Scholar
  16. 16.
    Steven L (2004) Total skin irradiation. In: Textbook of radiation oncology, 2nd edn. W B Saunders Co, PhiladelphiaGoogle Scholar
  17. 17.
    Miralbell R, Rouzaud M, Grob E, Nouet P, Bieri S, Majno SB, Botteron P, Montero M, Precoma JC (1994) Can a total body irradiation technique be fast and reproducible? Int J Radiat Oncol Biol Phys 29:1167–1173PubMedCrossRefGoogle Scholar
  18. 18.
    Lawton CA (1997) Total body irradiation for bone marrow transplantation. 39th annual meeting American Society for Therapeutic Radiology and Oncology. Orlando, Florida, Oct 1997Google Scholar
  19. 19.
    Kim TH, Gerbi BJ, Lo JN (1992) Total body irradiation for bone marrow transplantation. In: Levitt SH (ed) Levitt and Tapley’s, technological basis of radiation therapy: practical clinical applications, 2nd edn. Lea & Febiger, PhiladelphiaGoogle Scholar
  20. 20.
    Gerig LH, Szanto J, Bichay T, Genest P (1994) A translating-Bed technique for total-body irradiation. Phys Med Biol 39:19–35PubMedCrossRefGoogle Scholar
  21. 21.
    Beyzadeoglu M, Arpaci F, Surenkok S, Ozyigit G, Oysul K, Caglar K, Ataergin S, Yenicesu M, Kaya A (2008) Acute renal toxicity of 2 conditioning regimens in patients undergoing autologous peripheral blood stem-cell transplantation. Total body irradiation-cyclophosphamide versus ifosfamide, carboplatin, etoposide. Saudi Med J 29(6):832–836PubMedGoogle Scholar
  22. 22.
    Beyzadeoglu M, Ozyigit G, Ebruli C (2010) Basic radiation oncology, 1st edn. Springer, BerlinCrossRefGoogle Scholar
  23. 23.
    Jost LM (2005) Stahel RA; ESMO guidelines task force: ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin’s disease. Ann Oncol 16(Suppl 1):i54–i55PubMedCrossRefGoogle Scholar
  24. 24.
    Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin’s disease. International prognostic factors project on advanced Hodgkin’s disease. N Engl J Med 339(21):1506–1514PubMedCrossRefGoogle Scholar
  25. 25.
    Eich HT, Engenhart-Cabillic R, Hansemann K, Lukas P, Schneeweiss A, Seegenschmiedt H et al (2008) Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin’s lymphoma: an analysis of the German Hodgkin Study Group. Int J Radiat Oncol Biol Phys 71(5):1419–1424PubMedCrossRefGoogle Scholar
  26. 26.
    Eich HT, Diehl V, Gorgen H, Pabst T, Markova J, Debus J et al (2010) Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin’s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. J Clin Oncol 28(27):4199–4206PubMedCrossRefGoogle Scholar
  27. 27.
    Dabaja B, Cox JD, Buchholz TA (2007) Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin’s lymphoma. J Clin Oncol 25(1):3–5PubMedCrossRefGoogle Scholar
  28. 28.
    Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K et al (2008) Hodgkin disease/lymphoma. J Natl Compr Canc Netw 6(6):594–622PubMedGoogle Scholar
  29. 29.
    Phan J, Mazloom A, Jeffrey Medeiros L, Zreik TG, Wogan C, Shihadeh F et al (2010) Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol 28(27):4170–4176PubMedCrossRefGoogle Scholar
  30. 30.
    Persky DO, Unger JM, Spier CM, Stea B, LeBlanc M, McCarty MJ et al (2008) Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. J Clin Oncol 26(14):2258–2263PubMedCrossRefGoogle Scholar
  31. 31.
    Persky DO, Miller TP (2009) Localized large cell lymphoma: is there any need for radiation therapy? Curr Opin Oncol 21(5):401–406PubMedCrossRefGoogle Scholar
  32. 32.
    Kaminski MS, Coleman CN, Colby TV, Cox RS, Rosenberg SA (1986) Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy. Ann Intern Med 104(6):747–756PubMedGoogle Scholar
  33. 33.
    Sweet DL, Kinzie J, Gaeke ME, Golomb HM, Ferguson DL, Ultmann JE (1981) Survival of patients with localized diffuse histiocytic lymphoma. Blood 58(6):1218–1223PubMedGoogle Scholar
  34. 34.
    Wilder RB, Jones D, Tucker SL, Fuller LM, Ha CS, McLaughlin P et al (2001) Long-term results with radiotherapy for Stage I–II follicular lymphomas. Int J Radiat Oncol Biol Phys 51(5):1219–1227PubMedCrossRefGoogle Scholar
  35. 35.
    Advani R, Rosenberg SA, Horning SJ (2004) Stage I and II follicular non-Hodgkin’s lymphoma: long-term follow-up of no initial therapy. J Clin Oncol 22(8):1454–1459PubMedCrossRefGoogle Scholar
  36. 36.
    MacManus MP, Seymour JF (2001) Management of localized low-grade follicular lymphomas. Australas Radiol 45(3):326–334PubMedCrossRefGoogle Scholar
  37. 37.
    Lee CKK (2006) Radiotherapy for Hodgkin’s disease. In: Perez C, Vijayakumar S (eds) Technical basis of radiation therapy, 4th rev. edn. Springer, Berlin/HeidelbergGoogle Scholar
  38. 38.
    Müller RP, Bischof M (2006) Tumoren des lymphatischen systems. In: Wannenmacher M, Debus J, Wenz F (eds) Strahlentherapie. Springer, Berlin/Heidelberg, p 663Google Scholar
  39. 39.
    Gerbi BJ. Clinical applications of high-energy electrons. In: Perez C, Vijayakumar S (eds) Technical basis of radiation therapy, 4th rev. edn. Springer, Berlin/Heidelberg, p 818Google Scholar
  40. 40.
    Dusenbery KE, Gerbi BJ (2006) Total body irradiation conditioning regimens in stem cell transplantation. In: Perez C, Vijayakumar S (eds) Technical basis of radiation therapy, 4th rev. edn. Springer, Berlin/HeidelbergGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Murat Beyzadeoglu
    • 1
  • Gokhan Ozyigit
    • 2
  • Ugur Selek
    • 3
  • Ugur Selek
    • 4
  1. 1.Department of RadiationGulhane Military Medical SchoolEtlik, AnkaraTurkey
  2. 2.Department of Radiation Oncology Faculty of MedicineHacettepe UniversitySihhiye, AnkaraTurkey
  3. 3.MD Anderson Cancer CenterUniversity of TexasIstanbulTurkey
  4. 4.MD Anderson Radiation OncologyCenter at American Hospital-Istanbul NisantasiIstanbulTurkey

Personalised recommendations